The search for newer non-steroidal antiin‰ammatory drugs (NSAIDs) and the importance of oxadiazoles as antiin‰ammatory agents prompted us to undertake the synthesis of some novel oxadiazole and related analogues with unreported antiin‰ammatory activities. The antiin‰ammatory potential of the compounds was investigated using the carrageenan-induced rat paw edema method and cotton pellet-induced granuloma method. Some compounds demonstrated marked antiin‰ammatory activities. The antiin‰ammatory activity of oxadiazoles at doses of 100 mg/kg was shown by their ability to provide 28 55％, 21 36％, and 27 49％ protection against carrageenan-induced rat paw edema, moist cotton pellet-induced, and dry cotton pellet-induced granuloma, respectively. On the other hand, the antiin‰ammatory properties of oxadiazolines at doses of 100 mg/kg was re‰ected by their ability to provide 15 47％, 22 39％, and 23 47 ％ protection against carrageenan-induced rat paw edema, moist cotton pellet-induced, and dry cotton pellet-induced granuloma, respectively. Structure-activity relationships among synthesized compounds were also studied.
INTRODUCTION
Non-steroidal antiin‰ammatory drugs (NSAIDs) are widely used for the treatment of pain, fever, and in‰ammation. The pharmacologic activity of NSAIDs is related to the suppression of prostaglandin biosynthesis from arachidonic acid by inhibiting the enzyme cyclooxygenases (COX). With the chronic use of NSAIDs, one prominent side eŠect is the formation of gastric ulcers. This adverse eŠect may be attenuated in the presence of an inhibitor of 5-lipoxygenases (5-LOs). 1,3,4-Oxadiazoles have antiin‰ammatory properties by virtue of a dual mechanism, i.e., inhibiting both COX and LOs to reduce gastric ulcer formation. 1, 2) Numerous studies have been performed with the aim of exploring the antiin‰ammatory properties of 1,3,4-oxadiazole analogues. 3 7) Those studies found that 1,3,4-oxadiazole analogues are equipotent with phenylbutazone, naproxen and other NSAIDs. With the aim ofˆnding a COX/LO dual inhibitor, which may have improved e‹cacy and fewer side eŠects compared with existing NSAIDs, we considered it of interest to synthesize novel 1,3,4-oxadiazole analogues to investigate their antiin‰ammatory activities.
Compounds with an oxadiazole and oxadiazolin nucleus with a naphthalene-1-yloxymethyl substitution at the 5 position and substituted phenyl group at the 2 position have not been reported. Moreover, the synthetic strategy employed in their preparation is novel because no oxadiazole and oxadiazoline analogues with a naphthalene-1-yloxymethyl substitution have been prepared using oxidative cyclization with bromination in the presence of acetic acid.
MATERIALS AND METHODS

Chemistry
All the chemicals were from EMerck, Aldrich, and Himedia. Melting points were determined using the open capillary method and are uncorrected. Nitrogen estimation was done using an elemental analyzer Heraeus Carlo Erba-1108, IR spectra were recorded on a Perkin Elmer IR spectrophotometer (KBr disc), 13 C NMR spectra on a Bruker DRX-300 NMR spectrometer (DMSO-d 6 , TMS), and the electrospray mass spectra on a Micromass Quattro II triple-quadrupole mass spectrometer (methanol). The title compounds were prepared using the scheme described in Fig. 1 .
(Naphthalen-1-yloxy)-acetic acid ethyl ester (2) and (naphthalen-1-yloxy)-acetic acid hydrazide (3) were synthesized using the method reported earlier. 8, 9) 4-(Naphthalen-1-yloxy)-butyric acid-(4-substitutedbenzylidene)-hydrazide (4a-f): A solution of 3 (0.01 mol) was prepared in 50 ml of absolute ethanol in a round-bottomed ‰ask. The required aldehyde (0.01 mol) dissolved in 20 ml of absolute ethanol was added, dropwise to it, and the mixture was re‰uxed for 5  6 h. The solid mass, which separated out on cooling, wasˆltered andˆnally recrystallized from DMF/ water.
Compound 4a: yield 74％, mp 189 191°C, IR (KBr) 1695.1 (C＝O Str), 3345.3 (N H Str), 3072.6 (aromatic C H str), 1602.5, 1496.6 (aromatic C C Str).
2-( 4-Substituted-phenyl ) -5-( naphthalen-1-yloxymethyl)- [1, 3, 4] oxadiazole (5a f): A mixture of 4a f (0.01 mol), anhydrous sodium acetate (0.02 mol), and glacial acetic acid was placed in a round-bottomed ‰ask equipped with a separating funnel for the addition of bromine. Bromine (0.8 ml in 5 ml of glacial acetic acid) was added slowly to it while stirring magnetically. After 1.5 h of stirring, the solution was poured on crushed ice, and the resulting solid was separated, dried, and recrystallized from aldehydefree ethanol.
A mixture of 4a f (0.01 mol) and acetic anhydride (30 ml) was re‰uxed for 1 h. Excess acetic acid (byproduct) and acetic anhydride were removed by distillation under reduced pressure, and the residue obtained was recrystallized from aldehyde-free ethanol.
Pharmacology The antiin‰ammatory activity of test compounds in acute and chronic in‰ammatory conditions was evaluated using the carrageenan-induced rat paw edema method and cotton pellet-induced granuloma method, respectively. The carrageenan-induced in‰ammation model is a COXdependent reaction and is used to determine COX inhibition. The cotton pellet-induced granuloma method is widely used to evaluate the transudative and proliferative components of chronic in‰amma-tion.
For antiin‰ammatory evaluation, adult albino rats of either sex weighing 150 175 g were divided in groups of 6. All test compounds and indomethacin (reference drug) were administered orally suspended in 1％ carboxymethylcellulose (CMC). The acute oral toxicity test 10) was performed for all the synthesized compounds according to the Organization of Economic Cooperation and Development (OECD) guidelines. Statistical analyses were carried out with the single tailed t-test. A level of P＜0.001 was adopted as the test of signiˆcance. The procedure employed for antiin‰ammatory evaluation was reviewed and approved by the University Animal Ethical Committee. Acute oral toxicity was performed following the OECD-423 guidelines (acute toxic class method). Swiss albino mice (n＝3) of either sex selected by random sampling were used for the study. The animals were fasted for 3 4 h with water ad libitum, after which the test compounds (suspended in CMC) were administered orally at the dose of 5 mg/kg and the mice observed for 3 days. If mortality was observed in 2 to 3 animals, the dose administered was assigned as the toxic dose. If mortality was observed in 1 animal, then the same dose was repeated to conˆrm the toxic dose. In the present study, mortality was not observed with the 5 mg/kg dose and the procedure was repeated for higher doses of 50, 250, 500, 1000 and 2000 mg /kg. All 3 mice survived at the 2000 mg/kg dose, indicating that the compounds are nontoxic to animals.
Carrageenan-induced Rat Paw Edema Test The antiin‰ammatory activity of the synthesized compounds was assessed using the rat paw edema assay 11) utilizing 0.1 ml of 1％ carrageenan as a phlogistic agent. A mark was made on both hind paws just below the tibiotarsal junction so that the paw could be dipped in the mercury column of the plethysmograph up to the mark to ensure constant paw volume. To each group of 6 animals, with the exception of the control group, the test (100 mg/kg of body weight) compounds were administered orally. The control group received an equivalent amount of CMC used as solvent to dissolve the compounds. The standard drug indomethacin (10 mg/kg) was administered to one group. After 1 h, carrageenan (0.1 ml, 1％ w/v solution in sterile saline) was injected into the subplantar tissue of the left paw of the control as well as the indomethacin group. The right paw served as the reference non-in‰amed paw for comparison. The initial paw volume was measured using the plethysmograph within 30 sec after the injection. The relative increase in paw volume was measured in control, standard, and treated groups 1, 2, and 3 h after carrageenan injection. After 3 h, theˆnal paw volume of each animal was measured. The percent reduction in paw volume was calculated by subtracting the diŠerence between the right and left hind paw volumes in the treated group from the diŠerence in the control group and dividing by the diŠerence in the control group. The antiin‰ammatory activity of test compounds and the standard reference drug was determined using the formula ％ antiin‰ammatory activity＝(1-Vt/Vc)× 100, where Vt represents the mean increase in paw volume in rats treated with test compounds and Vc represents the mean increase in paw volume in the control group of rats.
Cotton Pellets-induced Granuloma Method After shaving the fur, rats were anesthetized and 10 ± 1 mg of sterile cotton pellets were inserted, one each in axilla. The test compounds, indomethacin and control vehicle, were administered orally for 7 consecutive days from the day of cotton pellet implantation. On the 8th day, animals were anesthetized and the cotton pellets were removed surgically and freed from extraneous tissues. The moist cotton pellets were weighed and then dried at 60°C for 24 h, and then the dried cotton pellets were weighed again. The actual weight of the cotton pellets was subtracted from the weight of dried granuloma pellets. The increase in the weight of dried cotton pellets was taken as the measure of granuloma formation. The antiproliferative eŠects of test compounds were determined by comparing the results obtained in test groups with those in the control group. 12) 
RESULTS AND DISCUSSION
The yield of theˆnal compounds, their melting points, and percentage nitrogen found are given in Table 1 . The structures of the compounds were elucidated on the basis of nitrogen analysis, IR, 13 C NMR, and electrospray mass spectroscopy (ESMS).
The IR data of synthesized oxadiazole analogues clearly shows a C＝N stretching band around 1640 cm . The IR data also conˆrm the presence of speciˆc functional groups present in theˆnal synthesized compounds. In the 13 C NMR spectra, C-2 and C-5 of the oxadiazole nucleus were seen around 165 and 172 ppm, respectively. All carbons and protons of theˆnal compounds were also seen based on the expected chemical shift. The mass spectra of test compounds are in conformity with the assigned structures. The mass spectra of these compounds showed molecular ion peaks corresponding to their molecular formula (Tables 2 and 3) .
The antiin‰ammatory activity of oxadiazoles, i.e., 5a f, at doses of 100 mg/kg is indicated by their ability to provide 28 55％, 21 36％ and 27 49％ protection against carrageenan-induced rat paw edema, moist cotton pellet-induced granuloma and dry cotton pellet-induced granuloma, respectively. On the other hand, the antiin‰ammatory properties of oxadiazolines, i.e., 6a f, at doses of 100 mg/kg is re‰ected by their ability to provide 15 47％, 22 39％, and 23 47％ protection against carrageenan-induced rat paw edema, moist cotton pellet-induced granuloma, and dry cotton pellet-induced granuloma, respectively ( Table 4) . Among the synthesized oxadiazoles, the maximum antiin‰ammatory activity was exhibited by compound 5e with 55.93％, 36.64％, and 49.33％ protection against carrageenan-induced rat paw edema, moist cotton pellet-induced granuloma, and dry cotton pellet-induced granuloma, respectively. In the case of oxadiazolines, the maximum activity was shown by compound 6e with 47.45％, 39.30％, and 47.79％ protection against carrageenan-induced rat paw oedema, moist cotton pellet-induced granuloma, and dry cotton pellet-induced granuloma, respectively.
In correlating the biological activity of compounds with their structure, it was observed that the most potent antiin‰ammatory compounds 5e and 6e had a hydroxy group on the benzene ring attached to C-2 of the oxadiazole and oxadiazoline moiety, respectively. The signiˆcant antiin‰ammatory activity of compounds 5e and 6e may be attributed to the electronegativity of the hydroxy group, which can withdraw electron more strongly than chloro, nitro, or other groups of the compounds. On the other hand, among all compounds, 5d and 6d had the weakest antiin‰ammatory activity. Another notable point is that compounds with the methoxy group, i.e., 5f and 6f, exhibited greater activity in comparison with compounds with the methyl group, i.e., 5d and 6d. This may be because the methoxy group supplies its electron more strongly than the methyl group, as the former group contains an electronegative oxygen atom. Replacement of the methyl group on the aryl moiety with other groups, i.e., hydroxy, nitro, and chloro groups, resulted in a considerable increase in antiin‰ammatory activity. Structure-activity relationships among the synthesized oxadiazole and oxadiazolines analogues indicates that the hydroxy, nitro, or chloro group in the aromatic ring is responsible for imparting signiˆcant antiin‰ammatory activity to the oxadiazole and oxadiazoline nucleus.
In conclusion, two novel series of compounds, 1,3,4-oxadiazole and oxadiazoline analogues, were synthesized for their potential antiin‰ammatory activities, using the carrageenan-induced rat paw edema method and cotton pellet-induced granuloma method. Among both series, the most potent antiin‰ammatory compounds were 5e, 5b, 5a, 6e, and 6b. In general, all the oxadiazoles have greater antiin‰ammatory activity than their corresponding oxadiazoline analogues. On the other hand, it can also be concluded that all the oxadiazole and related analogues exhibit greater antiin‰ammatory activity in the carrageenan-induced rat paw edema assay than in the cotton pellet-induced granuloma method, indicating that the studied compounds are more eŠective in acute in‰ammatory conditions than in chronic ones. In our laboratory, further research work is underway on optimization of the 1,3,4-oxadiazole lead to explore their antiin‰ammatory potential.
